About V-set and immunoglobulin domain-containing protein 1
V-set and immunoglobulin domain-containing protein 1 (VSIG1) is a protein
from Homo sapiens identified by UniProt accession
Q86XK7, 387 residues long.
MolForge cross-references it against 0 known binders and
53 disease associations.
Target properties
| Protein name | V-set and immunoglobulin domain-containing protein 1 |
| UniProt accession | Q86XK7 |
| Gene | VSIG1 |
| Organism | Homo sapiens |
| Length | 387 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (53)
Diseases linked to this target (Open Targets).
- Barrett's esophagus · score 0.07
- MALT lymphoma · score 0.06
- esophageal adenocarcinoma · score 0.06
- gonorrhea · score 0.05
- cancer · score 0.05
- neoplasm · score 0.05
- sessile serrated polyp · score 0.04
- CDH1-related diffuse gastric and lobular breast cancer syndrome · score 0.04
- Colon Sessile Serrated Adenoma/Polyp · score 0.04
- gastrointestinal stromal tumor · score 0.04
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q86XK7-F1 | alphafold | PREDICTED | 75.62 | — |
Amino-acid sequence (387 residues)
MVFAFWKVFL ILSCLAGQVS VVQVTIPDGF VNVTVGSNVT LICIYTTTVA SREQLSIQWS FFHKKEMEPI SIYFSQGGQA VAIGQFKDRI TGSNDPGNAS ITISHMQPAD SGIYICDVNN PPDFLGQNQG ILNVSVLVKP SKPLCSVQGR PETGHTISLS CLSALGTPSP VYYWHKLEGR DIVPVKENFN PTTGILVIGN LTNFEQGYYQ CTAINRLGNS SCEIDLTSSH PEVGIIVGAL IGSLVGAAII ISVVCFARNK AKAKAKERNS KTIAELEPMT KINPRGESEA MPREDATQLE VTLPSSIHET GPDTIQEPDY EPKPTQEPAP EPAPGSEPMA VPDLDIELEL EPETQSELEP EPEPEPESEP GVVVEPLSED EKGVVKA
Explore V-set and immunoglobulin domain-containing protein 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets